Scilligence
Private Company
Total funding raised: $7M
Overview
Scilligence is a private biotechnology informatics company offering an integrated software platform designed to streamline scientific R&D. Its core technology combines traditional data management systems (ELN, registration, inventory) with AI/ML capabilities for semantic search, retrosynthesis, and model building on chemical and biological data. The company targets both commercial biopharma and academic research sectors with a 'by scientists, for scientists' approach, focusing on improving data capture, collaboration, and innovation speed. Its business model is based on providing software platform services, positioning it as a Revenue Generating entity in the competitive lab informatics space.
Technology Platform
Integrated informatics platform featuring an Electronic Lab Notebook (ELN), Registration & Assay Database (RegMol), Materials Inventory, and Project Management Framework, enhanced by AI/ML tools for semantic search, retrosynthesis, and predictive modeling on chemical/biological data. Built on proprietary chemical sketching (JSDraw) and HELM capabilities.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Scilligence competes in the crowded laboratory informatics market against large players like Dassault Systèmes BIOVIA, Thermo Fisher Scientific, and LabVantage, as well as modern cloud-based platforms such as Benchling. Its differentiation hinges on its integrated platform, scientist-centric design, proprietary cheminformatics tools (JSDraw, HELM), and its focus on embedding AI/ML capabilities directly into the research workflow.